Price (delayed)
$0.157
Market cap
$4.09M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2
Enterprise value
$15.03M
heat biologics is a clinical-stage company focused on developing its proprietary impact™ (immune pan-antigen cytotoxic therapy), a fully allogeneic (“off-the-shelf”) cell-based immunotherapy for use in the treatment of a wide
There are no recent dividends present for SCPX.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.